Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Minoxidil tretinoin liposomal based hydrogel shows promise for effective treatment of hair loss by delivering both drugs at the same time.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Long-term steroid abuse in athletes causes serious health risks, outweighing any benefits.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Various treatments help hair growth, but more research needed for safety and effectiveness.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Nutricosmetics with active ingredients can help with hair loss and improve hair growth.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

EH-MSCs may help treat hair loss by reducing inflammation.

PRP can improve hair growth in androgenetic alopecia, but results vary.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Men with severe hair loss may have a higher risk of heart disease.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Low-level laser therapy improves hair growth and dermal papilla cell function.

Rosemary may improve scalp blood circulation and protect skin from sun damage.

Adipose-derived stem cell exosomes and AI can improve personalized skincare by offering anti-aging benefits and precise product customization.

New peptides can delay aging and improve cell function.